Guggenheim Maintains Buy on Acadia Healthcare Co, Raises Price Target to $39
Barclays Maintains Equal-Weight on Acadia Healthcare Co, Raises Price Target to $32
Acadia Healthcare Company, Inc. (ACHC) Q2 2026 Earnings Call Transcript
Acadia Healthcare Company, Inc. 2026 Q2 - Results - Earnings Call Presentation
Acadia Healthcare (ACHC) Falls on Soft Guidance Despite Earnings Beat
Acadia Healthcare Co Raises FY2026 Adj EPS Guidance from $1.35-$1.60 to $1.45-$1.60 vs $1.51 Est; Raises FY2026 Sales Guidance from $3.370B-$3.450B to $3.400B-$3.450B vs $3.409B Est
Guggenheim Maintains Buy on Acadia Healthcare Co, Raises Price Target to $38
TD Cowen Maintains Buy on Acadia Healthcare Co, Raises Price Target to $36
Keybanc Maintains Overweight on Acadia Healthcare Co, Raises Price Target to $40
UBS Maintains Buy on Acadia Healthcare Co, Raises Price Target to $39
Stronger Full‑Year Outlook But Softer Near‑Term Guidance Might Change The Case For Investing In Acadia (ACHC)
Q1 Earnings Outperformers: Acadia Healthcare (NASDAQ:ACHC) And The Rest Of The Hospital Chains Stocks
Why is Acadia Healthcare Company (ACHC) Highly Favored by Hedge Funds
Jefferies Upgrades Acadia Healthcare Co to Buy, Raises Price Target to $30
Buckley Capital’s Insights on Acadia Healthcare (ACHC)
How Investors May Respond To Acadia Healthcare (ACHC) Earnings Beat And Acute Psychiatric Revenue Momentum
Why Is Acadia Healthcare (ACHC) Down 8.2% Since Last Earnings Report?
3 Reasons to Avoid ACHC and 1 Stock to Buy Instead
Are Options Traders Betting on a Big Move in Acadia Healthcare Stock?
Acadia Healthcare Stock Soars 82% YTD: Time to Hold or Fold?
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.